腹腔镜循肝中静脉半肝切除术在原发性肝癌中的应用

doi:10.3760/cma.j.issn.2095-7041.2019.03.017

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1503 KB) HTML (2 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨腹腔镜循肝中静脉的半肝切除术治疗原发性肝癌的可行性、安全性及临床疗效。方法采用回顾性横断面研究方法。纳入2012年3月—2015年3月重庆医科大学附属第二医院和遂宁市中心医院肝胆外科采用腹腔镜循肝中静脉半肝切除术治疗原发性肝癌患者135例,其中男89例、女46例,年龄17~71岁,左半肝切除73例、右半肝切除62例。术后观察患者中转开腹率、手术时间、术中出血量、术中输血率、术后并发症、术后住院时间、术后总体生存率和无瘤生存率。结果 135例中,5.2%(7/135)中转开腹,手术时间为(315±86) min,术中出血量为(513±162) mL。5.9%(8/135)术中输血;12.6%(17/135)发生术后并发症,其中8.1%(11/135)为Clavien分级Ⅰ级、3.0%(4/135)为Clavien分级Ⅱ级、1.5%(2/135)例为Clavien分级Ⅲ~Ⅴ级;无死亡病例。116例纳入生存分析,中位随访时间34个月,1、3、5年总体生存率分别为92.6%、76.8%和64.4%,1、3、5年无瘤生存率分别为88.3%、69.2%和54.9%。结论在有经验的肝脏外科中心行腹腔镜下循肝中静脉的半肝切除术的风险可控,并发症少,疗效确切。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨小李
	吴涯昆
	程瑶
	李金政
	涂兵
	刘作金
	龚建平

关键词 ：肝肿瘤, 肝切除术, 腹腔镜, 肝中静脉

Abstract：Objective To evaluate the feasibility, safety and clinical efficacy of laparoscopic precise hemihepatectomy guided by middle hepatic vein in the treatment of primary liver cancer.Methods Retrospective cross-sectional study was adopted. The clinical and pathologic data of patients undergoing laparoscopic precise hemihepatectomy guided by middle hepatic vein at the Second Affiliated Hospital of Chongqing Medical University and Suining Central Hospital from March 2012 to March 2015 were analyzed. There were 89 males and 46 females aged from 17-71 years, including 73 patients of left hepatectomy and 62 patients of right hepatectomy. Conversion to laparotomy, operative time, intraoperative blood loss, intraoperative blood transfusion rate, postoperative complications, postoperative hospital stay, postoperative overall survival rate and recurrence-free survival rate were calculated.Results A total of 135 patients were included in the study, 5.2% (7/135) patients were converted to laparotomy. The operation time was (315±86) minutes. The intraoperative blood loss was (513±162) mL and 5.9% (8/135) cases needed intraoperative blood transfusion. 12.6% (17/135) cases had postoperative complications, of which 8.2% (11/135) were Clavien Grade Ⅰ, 3.0% (4/135) were Clavien Grade Ⅱ, and 1.5%(2/135) were Clavien Grade Ⅲ-Ⅴ, no deaths. One hundred and sixteen patients were included in the survival analysis. The median follow-up time was 34 months. The overall survival rates at 1, 3 and 5 years were 92.6%, 76.8% and 64.4%, respectively. The recurrence-free survival rates at 1, 3 and 5 years were 88.3%, 69.2% and 54.9%, respectively.Conclusions The risk of laparoscopic precise hemihepatectomy guided by middle hepatic vein in an experienced liver surgery center is controllable, with fewer complications and a definite curative effect.

Key words： Liver neoplasms Hepatectomy Laparoscopes Middle hepatic vein

收稿日期: 2018-07-11

通讯作者: 龚建平,Email:gongjianping11@126.com

引用本文:

杨小李, 吴涯昆, 程瑶, 李金政, 涂兵, 刘作金, 龚建平. 腹腔镜循肝中静脉半肝切除术在原发性肝癌中的应用[J]. 中华解剖与临床杂志, 2019, 24(3): 290-293.
Yang Xiaoli, Wu Yakun, Cheng Yao, Li Jinzheng, Tu Bing, Liu Zuojin, Gong Jianping. The application of laparoscopic precise hemihepatectomy guided by middle hepatic vein in the treatment of primary liver cancer. Chinese Journal of Anatomy and Clinics, 2019, 24(3): 290-293.

链接本文:

http://www.cjac.com.cn/CN/10.3760/cma.j.issn.2095-7041.2019.03.017 或 http://www.cjac.com.cn/CN/Y2019/V24/I3/290

[1]	董家鸿, 黄志强. 精准肝切除——21世纪肝脏外科新理念[J]. 中华外科杂志, 2009, 47(21): 1601-1605. DOI:10.3760/cma.j.issn.0529-5815.2009.21.001.
[2]	仇毓东, 朱新华, 朱日祥, 等. 循肝中静脉精准半肝切除疗效的前瞻性研究[J]. 中华消化外科杂志, 2011, 10(4): 256-259. DOI:10.3760/cma.j.issn.1673-9752.2011.04.005.
[3]	Xiang L, Li J, Chen J, et al. Prospective cohort study of laparoscopic and open hepatectomy for hepatocellular carcinoma[J]. Br J Surg, 2016, 103(13): 1895-1901. DOI:10.1002/bjs.10294.
[4]	Studer P, Horn T, Haynes A, et al. Quality of life after hepatic resection[J]. Br J Surg, 2018, 105(3): 237-243. DOI:10.1002/bjs.10735.
[5]	中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华肝脏病杂志,2017, 25(12): 886-895. DOI:10.3760/cma.j.issn.1007-3418.2017.12.002.
[6]	Cheung TT, Han HS, She WH, et al. The Asia pacific consensus statement on laparoscopic liver resection for hepatocellular carcinoma: a report from the 7th asia-pacific primary liver cancer expert meeting held in Hong Kong[J]. Liver Cancer, 2018, 7(1): 28-39. DOI:10.1159/000481834.
[7]	Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience[J]. Ann Surg, 2011, 253(4): 745-758. DOI:10.1097/SLA.0b013e3182111195.
[8]	李建伟, 王小军, 曹利, 等. 2048例腹腔镜肝切除术的临床疗效及经验总结[J]. 中华消化外科杂志, 2017, 16(8): 818-821. DOI:10.3760/cma.j.issn.1673-9752.2017.08.012.
[9]	van der Poel MJ, Besselink MG, Cipriani F, et al. Outcome and learning curve in 159 consecutive patients undergoing total laparoscopic hemihepatectomy[J]. JAMA Surg, 2016, 151(10): 923-928. DOI:10.1001/jamasurg.2016.1655.
[10]	Zhang Y, Chen XM, Sun DL. Short-term outcomes of laparoscopic versus open right hemihepatectomy for hepatocellular carcinoma[J]. Surg Laparosc Endosc Percutan Tech, 2016, 26(6): e157-e160. DOI:10.1097/SLE.0000000000000355.
[11]	Kang WH, Kim KH, Jung DH, et al. Long-term results of laparoscopic liver resection for the primary treatment of hepatocellular carcinoma: role of the surgeon in anatomical resection[J]. Surg Endosc, 2018, 32(11): 4481-4490. DOI:10.1007/s00464-018-6194-0.
[12]	孙士全, 毛谅, 仇毓东. 循中肝静脉半肝切除的技术要点[J]. 肝胆外科杂志, 2017, 25(4): 247-249. DOI:10.3969/j.issn.1006-4761.2017.04.004.
[13]	Han HS, Shehta A, Ahn S, et al. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching[J]. J Hepatol, 2015, 63(3): 643-650. DOI:10.1016/j.jhep.2015.04.005.
[14]	Shehta A, Han HS, Yoon YS, et al. Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience[J]. Surg Endosc, 2016, 30(2): 638-648. DOI:10.1007/s00464-015-4253-3.
[15]	Yoon YI, Kim KH, Kang SH, et al. Pure laparoscopic versus open right hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score matched analysis[J]. Ann Surg, 2017, 265(5): 856-863. DOI:10.1097/SLA.0000000000002072.